Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants-Reference-Cited by-同舟云学术

Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants

Published:2020-04-16 Issue:9 Volume:60 Page:1157-1165
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Ankrom Wendy¹,Xu Jialin¹,Vallee Marie‐Helene¹,Dockendorf Marissa F.¹,Armas Danielle²,Boinpally Ramesh³,Min K. Chris¹

Affiliation:

1. Research LaboratoriesMerck & Co, Inc Kenilworth New Jersey USA

2. Celerion Inc Phoenix Arizona USA

3. Allergan plc Madison New Jersey USA

Funder

Allergan plc, Dublin, Ireland

Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1610

Reference31 articles.

1. Sex Differences in the Prevalence, Symptoms, and Associated Features of Migraine, Probable Migraine and Other Severe Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study

2. Prevalence of Migraine Headache in the United States

3. Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II

4. Migraine is first cause of disability in under 50s: will health politicians now take notice?

5. Desogestrel-only contraception may reduce headache frequency and improve quality of life in women suffering from migraine

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of a High‐Fat Meal on the Pharmacokinetics of an Immediate Release Atogepant Tablet;Clinical Pharmacology in Drug Development;2024-07-12

2. The preclinical discovery and development of atogepant for migraine prophylaxis;Expert Opinion on Drug Discovery;2024-06-10

3. Pharmacokinetics and Safety of Atogepant Co‐administered with Quinidine Gluconate in Healthy Participants: A Phase 1, Open‐Label, Drug‐Drug Interaction Study;Clinical Pharmacology in Drug Development;2024-05-03

4. Lomitapide as a Potential Estrogen Receptor Inhibitor: A Computational Drug Repurposing Study;Kocaeli Üniversitesi Sağlık Bilimleri Dergisi;2024-03-15

5. Evaluation of the pharmacokinetic interactions and safety of atogepant coadministered with esomeprazole;Pain Management;2023-06